Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). Given the alarming and noticeable increase in ayahuasca border seizures in 2020, the main intent of these initial requests was to see how many seizures happened that year and if the government had a specific policy regarding these seizures. Customs Border Patrol (“CBP”) and U.S. 562 [2011]).

DEA 97

DEA Blood Pressure Safety Policy 97

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

AUGUST 23, 2023

A disputable new social media drug reporting bill believes that social media companies should screen client posts and report any drug-related exercises to the DEA. It is critical that the perspectives of groups who are most affected by drug enforcement policies are centered in these conversations around reform.

Media 52

Media DEA Advocacy Legislation 52

Cannabis Law Report

JULY 13, 2021

The California legislation that would decriminalize some psychedelic substances under state law, Senate Bill 519, was approved in a 5-3 vote by the State Assembly’s Public Safety Committee in a June 29th hearing. This vote marks the bill’s first hearing in the Assembly after passing in a 21-16 vote by the State Senate on June 1.

Decriminalization 105

Decriminalization Legislation DEA Safety 105

Canna Law Blog

JULY 14, 2023

But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. FTC Policy Statement on Deception, 103 F.T.C. For now, stay tuned to the Canna Law Blog for more updates on FDA and FTC cannabinoid policies and delta-8 products. You can read more about that issue here or here.

Packaging 74

Packaging Food Edibles THC 74

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 30, 2021

With hemp already federally legal, a primary policy issue is how marijuana and hemp—two varieties of the cannabis plant—would be distinguished under a federal regulatory regime. We strongly encourage participation in this important opportunity to shape federal cannabis policy. Distinction between Cannabis and Hemp Under the CAOA.

Hemp 105

Hemp Law Seed-To-Sale Food 105

FloridaMarijuana.net

JULY 8, 2018

According to the MAPS website they are “working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). Food and Drug Administration.

Strains 190

Strains Indica Hybrid Research and Development 190

SpeedWeed

APRIL 27, 2021

“But my contacts at the American Herbal Products Association, as well as the DEA (Drug Enforcement Administration) and the American Western Hemp Professionals, and the U.S. Anecdotally, we understand that the DEA is actively monitoring the proliferation of delta-8 THC products.”. Andrea Golan, cannabis industry lawyer.

Legalization 52

Legalization DEA Supply Chain Hemp 52

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Provisions.

Research and Development 105

Research and Development DEA Programs State Laws 105

SpeedWeed

APRIL 1, 2021

As federal and state governments tackle the legalization of hemp as a distinct product from cannabis, the safety of the products produced from hemp isn’t getting the same attention as those produced from THC-based cannabis. Testing failures highlight the need for national regulations on hemp.

THC 52

THC Hemp CBD Vaping 52

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 109

Legalization Decriminalization Medicine Research and Development 109

Cannabis Law Report

JULY 2, 2019

Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.

Compliance 40

Compliance Compliance Programs CBD 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

SpeedWeed

JUNE 8, 2021

Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S.

Topical 40

Topical THC Cannabinoids Agriculture 40

Cannabis Law Report

FEBRUARY 25, 2019

There are remaining concerns as to the state health department’s treatment policy towards these products as well. Ohio, Texas and Maine have also experienced adverse enforcement activities, and other states such as North Carolina are threatening the same.

CBD 71

CBD Food Compliance Compliance 71

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al., 21 × 21.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

MAY 25, 2022

The court also considered Boyd Street’s counterarguments that (1) DEA has interpreted the 2018 Farm Bill as inapplicable to delta-8 THC due to its method of manufacture and (2) Congress never intended for the Act to legalize any psychoactive substance. as opposed to delta-8 THC or total THC (i.e., The Implications.

THC 52

THC Legalization Hemp Concentrates 52

SpeedWeed

AUGUST 19, 2021

And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . While THC-O products like vape carts and tinctures are available for purchase online, both their legal status and their safety remain unproven. . View original article.

THC 52

THC Hemp Extraction Vaping 52

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. Research quality” cannabis sparked earlier controversy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .” Safety The Problem with Percentages As mentioned earlier, the 0.3

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. The Florida Highway Patrol Policy Manual outlines these rights.

Law 126

Law Marijuana Patients Treatment 126

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 60

Marijuana Therapy Data THC 60

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

MAY 1, 2019

8 In January of this year, Attorney General Jeff Sessions rescinded an Obama-era policy which had de-prioritized federal prosecution of those involved in the cannabis industry in states which had legalized medical or recreational cannabis. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.” Table of Contents. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JULY 27, 2022

As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S.

Marijuana 52

Marijuana DEA State Laws Policy 52

Canna Law Blog

MARCH 4, 2020

And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Therapy 88

Therapy Legalization Chronic Pain DEA 88

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

SpeedWeed

SEPTEMBER 7, 2021

There was no testing information, no information about the manufacturer, no product safety assurance whatsoever. . In fact, the federal government’s trademark policies are encouraging pirate manufacturers to cheat delta-8 consumers nationwide—and put the public’s health at risk. . DEA’s July 2021 update. Not a whole lot.

Vaping 52

Vaping DEA Oil Packaging 52

Cannabis Law Report

MAY 24, 2022

Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions. The criminalization of marijuana was the result of racially motivated policies, such as the Marijuana Tax Act of 1937. The Tax Act was litigated in Leary v.

DEA 52

DEA History Medicine Marijuana 52